Tiziana Life Sciences annual shares outstanding
2018
2019
2020
2021
2022
2023
2024
2025
Tiziana Life Sciences Shares Outstanding History (TLSA)
Tiziana Life Sciences reported 120.5M shares outstanding at the end of fiscal 2025.
View full Tiziana Life Sciences company overviewTiziana Life Sciences annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 120.5M | 9.0M | +8.11% |
| 2024 | 2024-12-31 | 111.5M | 8.4M | +8.12% |
| 2023 | 2023-12-31 | 103.1M | 815,130 | +0.80% |
| 2022 | 2022-12-31 | 102.3M | 0 | 0.00% |
| 2021 | 2021-12-31 | 102.3M | −92.3M | −47.45% |
| 2020 | 2020-12-31 | 194.6M | 58.0M | +42.41% |
| 2019 | 2019-12-31 | 136.7M | 190,698 | +0.14% |
| 2018 | 2018-12-31 | 136.5M | — | — |
Tiziana Life Sciences quarterly shares outstanding
Q4.17
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 120.5M | 9.0M | +8.11% |
| Q2 2025 | 2025-06-30 | 118.9M | — | — |
| Q4 2024 | 2024-12-31 | 111.5M | 8.4M | +8.12% |
| Q4 2023 | 2023-12-31 | 103.1M | 815,130 | +0.80% |
| Q4 2022 | 2022-12-31 | 102.3M | 0 | 0.00% |
| Q4 2021 | 2021-12-31 | 102.3M | −92.3M | −47.45% |
| Q4 2020 | 2020-12-31 | 194.6M | 58.0M | +42.41% |
| Q4 2019 | 2019-12-31 | 136.7M | 190,698 | +0.14% |
| Q4 2018 | 2018-12-31 | 136.5M | 0 | 0.00% |
| Q4 2017 | 2017-12-31 | 136.5M | — | — |
Tiziana Life Sciences shares outstanding trends
Over the last five fiscal years, Tiziana Life Sciences's shares outstanding moved from 194.6M to 120.5M, a change of −74.1M. The latest reported quarter, Q4 2025, shows 120.5M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tiziana Life Sciences source filings ↗